23.99 USD
+0.01 (+0.04%)
23.99 USD
0 (0%)
Overall ABCM gets a fundamental rating of 5 out of 10. We evaluated ABCM against 530 industry peers in the Biotechnology industry. Both the profitability and the financial health of ABCM get a neutral evaluation. Nothing too spectacular is happening here. ABCM is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year ABCM was profitable.
ABCM had a positive operating cash flow in the past year.
1.2 Ratios
ABCM's Return On Assets of 0.64% is amongst the best of the industry. ABCM outperforms 93.86% of its industry peers.
ABCM has a better Return On Equity (0.93%) than 93.86% of its industry peers.
ABCM's Return On Invested Capital of 1.98% is amongst the best of the industry. ABCM outperforms 94.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ABCM is significantly below the industry average of 18.28%.
The last Return On Invested Capital (1.98%) for ABCM is well below the 3 year average (6.00%), which needs to be investigated, but indicates that ABCM had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROIC | 1.98% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
1.3 Margins
With an excellent Profit Margin value of 1.94%, ABCM belongs to the best of the industry, outperforming 94.86% of the companies in the same industry.
In the last couple of years the Profit Margin of ABCM has declined.
ABCM has a better Operating Margin (8.70%) than 95.36% of its industry peers.
ABCM's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 72.69%, ABCM belongs to the top of the industry, outperforming 83.58% of the companies in the same industry.
ABCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% |
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABCM is destroying value.
ABCM has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ABCM has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.64 indicates that ABCM is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.64, ABCM belongs to the best of the industry, outperforming 85.41% of the companies in the same industry.
The Debt to FCF ratio of ABCM is 19.99, which is on the high side as it means it would take ABCM, 19.99 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 19.99, ABCM belongs to the top of the industry, outperforming 94.03% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that ABCM is not too dependend on debt financing.
ABCM has a worse Debt to Equity ratio (0.30) than 71.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Altman-Z | 8.64 |
ROIC/WACC0.22
WACC8.89%
2.3 Liquidity
A Current Ratio of 1.26 indicates that ABCM should not have too much problems paying its short term obligations.
ABCM has a worse Current ratio (1.26) than 86.73% of its industry peers.
ABCM has a Quick Ratio of 1.26. This is a bad value and indicates that ABCM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ABCM (0.98) is worse than 88.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
ABCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 402.64%, which is quite impressive.
ABCM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.30% yearly.
The Revenue has grown by 17.70% in the past year. This is quite good.
The Revenue has been growing by 11.64% on average over the past years. This is quite good.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
3.2 Future
ABCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.12% yearly.
The Revenue is expected to grow by 11.28% on average over the next years. This is quite good.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 44.43 indicates a quite expensive valuation of ABCM.
Based on the Price/Earnings ratio, ABCM is valued cheaper than 94.69% of the companies in the same industry.
ABCM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.60.
The Price/Forward Earnings ratio is 49.32, which means the current valuation is very expensive for ABCM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABCM indicates a rather cheap valuation: ABCM is cheaper than 94.53% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ABCM to the average of the S&P500 Index (23.23), we can say ABCM is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ABCM is valued cheaply inside the industry as 94.20% of the companies are valued more expensively.
93.86% of the companies in the same industry are more expensive than ABCM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 374.67 | ||
| EV/EBITDA | 55.61 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ABCM has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ABCM's earnings are expected to grow with 52.49% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%
5. Dividend
5.1 Amount
ABCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.99
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Revenue(TTM)350.40M
Net Income(TTM)6.80M
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 | ||
| P/S | 12.3 | ||
| P/FCF | 374.67 | ||
| P/OCF | 79.64 | ||
| P/B | 5.92 | ||
| P/tB | 42.37 | ||
| EV/EBITDA | 55.61 |
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROCE | 3.54% | ||
| ROIC | 1.98% | ||
| ROICexc | 2.23% | ||
| ROICexgc | 7.95% | ||
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% | ||
| FCFM | 3.28% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexgc growth 3Y-57.08%
ROICexgc growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Debt/EBITDA | 2.79 | ||
| Cap/Depr | 90.64% | ||
| Cap/Sales | 12.16% | ||
| Interest Coverage | 9.53 | ||
| Cash Conversion | 69.81% | ||
| Profit Quality | 169.12% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 8.64 |
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%
ABCAM PLC-SPON ADR / ABCM FAQ
Can you provide the ChartMill fundamental rating for ABCAM PLC-SPON ADR?
ChartMill assigns a fundamental rating of 6 / 10 to ABCM.
Can you provide the valuation status for ABCAM PLC-SPON ADR?
ChartMill assigns a valuation rating of 7 / 10 to ABCAM PLC-SPON ADR (ABCM). This can be considered as Undervalued.
What is the profitability of ABCM stock?
ABCAM PLC-SPON ADR (ABCM) has a profitability rating of 8 / 10.
What is the valuation of ABCAM PLC-SPON ADR based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABCAM PLC-SPON ADR (ABCM) is 44.43 and the Price/Book (PB) ratio is 5.92.
What is the earnings growth outlook for ABCAM PLC-SPON ADR?
The Earnings per Share (EPS) of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 125.95% in the next year.